Who invested in Turning Point Therapeutics?
Turning Point Therapeutics's investors include OrbiMed, Cormorant Asset Management, SR One, Foresite Capital and Lilly Asia Ventures.
Who invested in Turning Point Therapeutics
Funding summaryUpdated 26 Oct 2026
$460Mraised across 1 round since 2020, from 1 source
- Latest round
- Round, $460MOct 2020
- Investors
- 5
The rounds
- Oct 2020
Everyone who backed them
Lilly Asia VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Turning Point Therapeutics
How much has Turning Point Therapeutics raised?
Turning Point Therapeutics has raised $460M across 1 round since 2020.
When did Turning Point Therapeutics last raise?
Turning Point Therapeutics's most recent round was an Undisclosed round of $460M in Oct 2020.
What was Turning Point Therapeutics's biggest round?
Its most recent round, $460M in Oct 2020, is also its largest on record.
Who backed Turning Point Therapeutics first?
Turning Point Therapeutics's first round on record, in Oct 2020, was backed by OrbiMed, Cormorant Asset Management and SR One and 2 others.
What stage is Turning Point Therapeutics at?
Turning Point Therapeutics's latest named round is an Undisclosed round, in Oct 2020.
Companies like Turning Point Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.